Abstract
Physician-Assisted Suicide (PAS) is considered by some patients who learn they are at risk for a
cognitive decline owing to Alzheimer’s Disease. At the same time, the prospect of PAS may
raise patients’ fear of imminent death. Can PAS be offered in a way that is preference-sensitive
on one hand, and mitigates patients’ fear of imminent death on the other? A thought experiment
of a Probabilistic Approach to PAS (Probabilistic PAS) is proposed here as a possible solution in
jurisdictions where PAS is legal.
Consider the following scenario: A patient diagnosed with Alzheimer’s Disease who is
considering PAS might request that when he or she can no longer recognize their loved ones,
their doctor will give them a lethal pill that has a 1/100 daily probability of being activated. As a
result, after taking the pill, every day the patient will have a 1/100 probability of dying. The
likelihood of the patient dying within a year from taking the pill is 97.4%, and within two years,
it is 99.9%. As such, a Probabilistic PAS with which on any given day the probability of dying is
low, can help patients avoid the fear of imminent death – which traditional PAS entails – while
respecting their preference to end their lives.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted January 25, 2023. ; https://doi.org/10.1101/2023.01.24.23284910doi: medRxiv preprint
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
To examine the potential reception of a Probabilistic PAS, a survey was administered to a
nationally-representative sample of US residents, using Prolific, a research participant
recruitment platform. 499 participants were presented with a short description of a patient who
was diagnosed with Alzheimer’s Disease, is writing an advance directive and is considering
ways to end their life painlessly when they can no longer recognize their loved ones. Participants
were asked about their own preferences in case they were to face a similar situation, and whether
helping administer Probabilistic PAS would be ethical for the patient’s provider.
498 participants responded to the question about their own preference. 73.5% indicated that they
would choose one of the two PAS options. Among those, 9.8% preferred a Probabilistic PAS
over traditional PAS. Men were more likely than women to favor Probabilistic PAS for
themselves. 482 participants indicated which option would be most ethical for the patient’s
provider to administer. 48.1% indicated one of the two PAS options as most ethical. Among
those, 10.3% considered Probabilistic PAS to be more ethical than traditional PAS. Men were
more likely than women to consider the provider administering Probabilistic PAS to be most
ethical.
A version of the Probabilistic PAS proposed here should be considered as a preference-sensitive
option presented by healthcare providers to patients considering advance care planning in places
where PAS is available.
Keywords
Physician-Assisted Suicide; Physician-Assisted Death
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted January 25, 2023. ; https://doi.org/10.1101/2023.01.24.23284910doi: medRxiv preprint
Introduction
Physician-Assisted Suicide (PAS) is considered by some patients who learn they are at risk for a
cognitive decline owing to Alzheimer’s Disease1,2. At the same time, the prospect of PAS may
raise patients’ fear of imminent death. Can PAS be offered in a way that is preference-sensitive
on one hand, and mitigates patients’ fear of imminent death on the other? A thought experiment
of a Probabilistic Approach to PAS (Probabilistic PAS) is proposed here as a possible solution in
jurisdictions where PAS is legal, and the results of a US nationally representative sample survey
of responses to it are presented.
Consider the following scenario: A patient diagnosed with Alzheimer’s Disease who is
considering PAS might request that when he or she can no longer recognize their loved ones,
their doctor will give them a lethal pill that has a 1/100 daily probability of being activated. As a
result, after taking the pill, every day the patient will have a 1/100 probability of dying. The
likelihood of the patient dying within a year from taking the pill is 97.4%, and within two years,
it is 99.9%. As such, a Probabilistic PAS with which on any given day the probability of dying is
low, can help patients avoid the fear of imminent death – which traditional PAS entails – while
respecting their preference to end their lives.
Methods
To examine the potential reception of a Probabilistic PAS, a survey was administered to a
nationally-representative sample of US residents, using Prolific, a research participant
recruitment platform. 499 participants (252 women; 240 men; 7 other; mean age: 46.2, SD: 16.6)
were presented with a short description of a patient who was diagnosed with Alzheimer’s
Disease, is writing an advance directive and is considering ways to end their life painlessly when
they can no longer recognize their loved ones
3. Participants were asked about their own
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted January 25, 2023. ; https://doi.org/10.1101/2023.01.24.23284910doi: medRxiv preprint
preferences in case they were to face a similar situation, and whether helping administer
Probabilistic PAS would be ethical for the patient’s provider. In responding to the questions,
participants had to choose between three alternatives including traditional PAS, a Probabilistic
PAS, and no PAS. The choice order presented to participants was randomized. The study was
approved by NYU Institutional Review Board (IRB-FY2022-6529).
Results
498 participants (252 women; 239 men; 7 other) responded to the question about their own
preference. 366 (73.5%) indicated that they would choose one of the two PAS options
(traditional PAS and Probabilistic PAS). Among those, 36 (9.8%) preferred a Probabilistic PAS
over traditional PAS. Men were more likely than women to favor Probabilistic PAS for
themselves (23/239 vs. 13/252; p<0.01). 482 participants (242 women; 233 men; 7 other)
indicated which option would be most ethical for the patient’s provider to administer. 232
(48.1%) indicated one of the two PAS options as most ethical. Among those, 24 (10.3%)
considered Probabilistic PAS to be more ethical than traditional PAS. Men were more likely than
women to consider the provider administering Probabilistic PAS to be most ethical (18/233 vs.
6/241; p<0.01). In both cases, age was negatively associated with a PAS preference over no PAS
(p<0.01). Age was not associated with a Probabilistic PAS preference.
Discussion
A Probabilistic PAS is outlined as a thought experiment to inform the scholarly discussion of
PAS
4,5. Probabilistic PAS represents an alternative to the life/death binary choice currently
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted January 25, 2023. ; https://doi.org/10.1101/2023.01.24.23284910doi: medRxiv preprint
available to patients in jurisdictions were PAS is legal, and offers an additional avenue for
decision making autonomy. To examine its possible reception, Probabilistic PAS was presented
to a US nationally representative sample. The Probabilistic PAS option was preferred by a
minority of those who indicated a preference for PAS if they were to learn they are likely to
suffer from Alzheimer’s Disease. A version of the Probabilistic PAS proposed here should be
considered as a preference-sensitive option presented by healthcare providers to patients
considering advance care planning in places where PAS is available6.
References
1. Largent, E.A., Terrasse, M., Harkins, K., Sisti, D.A., Sankar, P. and Karlawish, J., 2019.
Attitudes toward physician-assisted death from individuals who learn they have an
Alzheimer disease biomarker. JAMA Neurology, 76(7), pp.864-866.
2. Sulmasy, Daniel P., E. Wesley Ely, and Charles L. Sprung. 2016. Euthanasia and physician-
assisted suicide. JAMA 316, no. 15, 1600-1600.
3. Bravo, G., Rodrigue, C., Arcand, M., Downie, J., Dubois, M.F., Kaasalainen, S., Hertogh,
C.M., Pautex, S., Van den Block, L. and Trottier, L., 2018. Quebec physicians’ perspectives
on medical aid in dying for incompetent patients with dementia. Canadian Journal of Public
Health, 109(5), pp.729-739.
4. Florijn, B.W., 2022. The Principle of Autonomy in Biomedical-and Neuroethics. The
American Journal of Bioethics, 22(10), pp.W9-W11.
5. Kim, S.Y., 2022. The Unstable Boundary of Suffering-Based Euthanasia Regimes. The
American Journal of Bioethics, 22(2), pp.59-62.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted January 25, 2023. ; https://doi.org/10.1101/2023.01.24.23284910doi: medRxiv preprint
6. Barone, S. and Unguru, Y., 2017. Should euthanasia be considered iatrogenic?. AMA Journal
of Ethics, 19(8), pp.802-814.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted January 25, 2023. ; https://doi.org/10.1101/2023.01.24.23284910doi: medRxiv preprint
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.